Warner Bros. Discovery, Inc.
Biphenyl Compound As CCR2/CCR5 Receptor Antagonist
Last updated:
Abstract:
Provided is a CCR2/CCR5 receptor antagonist and the use thereof in the preparation of a drug for treating diseases associated with the CCR2/CCR5. In particular, disclosed are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
11 Dec 2017
Issue date:
16 Jul 2020